## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -4.0% below STRENGTH zone (4.0-10.0%); PEG 1.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Hormel Foods Reinvents the Center of the Plate: How a Legacy Brand Is Turning Pantry Staples into a**
- Source: AD HOC NEWS | 20260105T222700 | Bullish | Relevance: 100%
- Hormel Foods is transforming from a traditional canned-meat company into a diverse protein and snacking platform, focusing on convenience, premiumization, and healthier options. The company is strategically diversifying its brand portfolio, which includes Spam, Skippy, Planters, and Applegate, to cater to varying consumer needs from value-driven to health-conscious. This reinvention aims to solidify its competitive edge in a crowded market by offering a comprehensive protein ecosystem to retailers and consumers.

**2. Hormel Foods Stock Tests Investor Patience As Defensive Story Meets Valuation Gravity**
- Source: AD HOC NEWS | 20260103T040821 | Neutral | Relevance: 100%
- Hormel Foods (HRL) stock is currently in a consolidation phase, testing investor patience as it struggles with slowing growth and margin pressure despite its defensive qualities and dividend history. The market is caught between long-term holders waiting for a rebound and new investors seeing it as a discounted dividend aristocrat. Future performance hinges on the company's ability to demonstrate visible progress on margins and earnings growth.

**3. Hormel Foods (NYSE:HRL) Rating Lowered to Sell at Wall Street Zen**
- Source: MarketBeat | 20260103T062744 | Somewhat-Bearish | Relevance: 96%
- Wall Street Zen has downgraded Hormel Foods (NYSE:HRL) from "hold" to "sell," leading to a current consensus rating of "Hold" and a target price of $28.29. Despite recently beating EPS estimates, the company missed revenue forecasts and issued modest FY2026 guidance. Hormel Foods opened at $23.39 on Friday, indicating it is trading below its consensus target price.

**4. Smucker (J.M.) Co.: How a Legacy Pantry Brand Is Rebuilding Its Power Portfolio**
- Source: AD HOC NEWS | 20260104T035433 | Neutral | Relevance: 64%
- J.M. Smucker Co. is transforming its century-old business into a modern, brand-driven powerhouse by focusing on key growth engines like Uncrustables, specific coffee brands, and its refocused pet food portfolio. The company employs strategies such as category concentration, operational scale, and leveraging strong brand equity to compete in the challenging consumer goods market against major rivals like General Mills and Kellogg's. This strategic re-evaluation and targeted investment aim to drive sustained growth and strong financial performance for the legacy brand.

**5. Smucker (J.M.) Co.: How a Legacy Pantry Brand Is Rebuilding Its Power Portfolio**
- Source: AD HOC NEWS | 20260104T040838 | Somewhat-Bullish | Relevance: 60%
- J.M. Smucker Co. is transforming its century-old pantry business into a modern, brand-driven powerhouse by focusing on key segments like coffee, Uncrustables, Jif peanut butter, and a streamlined pet food portfolio. The company counters tough market competition by concentrating on specific usage occasions, leveraging operational scale, maintaining strong brand equity, and strategically pruning its portfolio for higher-growth, higher-margin businesses. This strategy aims to provide dependable cash flows and selective growth engines, influencing the company's valuation and stock performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 8 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.8% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 15.3% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.62 elevated, pricing in significant growth expectations. Forward P/E 14.7x stretched relative to 6% growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.6B |
| Beta | 0.32 |
| 52W Range | $21.03 - $32.07 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.62 |
| Forward P/E | 14.7 |
| Current P/E | 15.7 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.8% to -4.0% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). AM_20 at -3.8% indicates price below own 20MA trend. Below SMA200 (0.85x), long-term trend not supportive. OFD pattern: -STN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.98% (CS: 9) | Weak |
| RSI_14 | 39.2 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.962x | Below |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 0.847x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $22.96
- **Stop Loss:** $22.08 (3.8% risk)
- **Target:** $23.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 653
- **Position Value:** $14,992.88
- **Portfolio %:** 14.99%
- **Risk Dollars:** $575.00
- **Risk Per Trade:** 0.57%
- **Modifiers:** L1 115% | L2 50% | Combined 0.57x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*